Drawing for ARRAY CYTOMETRY

USPTO serial 76339812

ARRAY CYTOMETRY

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
Examiner
MICHOS, JOHN E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARRAY CYTOMETRY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric P. Mirabel

ERIC P MIRABEL BIOARRAY SOLUTIONS LTD35 TECHNOLOGY DRWARREN, NJ 07059UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Preparations for scientific and research use, namely, biological or biotechnical arrays and assemblies of constituents of biological cells, methods, tests, kits consisting of the aforementioned; biological preparations for random encoded array detection to record optical signatures from cells randomly dispersed in a planar array or assembly and optically programmable reconfiguration and segmentation of assemblies cells; a highly parallel assay format that is useful for a wide variety of multiplexed bioanalytical assays, including functional and structural cellular analysis that is enabled by the optically programmable assembly and manipulation of cells (e.g., bacterial, yeast and human) providing quantitative, multi parameter cell surface analysis by direct imagining as well as fractionation and sorting of mixed cell populationsACTIVE
035Distribution of services in the field of biological or biotechnical arrays and assemblies of constituents of biological cells, methods, tests, kits, or apparatus therefor; random encoded array detection to record optical signatures from cells randomly dispersed in a planar array or assembly and optically programmable reconfiguration and segmentation of assemblies cells; a highly parallel assay format that is useful for a wide variety of multiplexed bioanalytical assays, including functional and structural cellular analysis that is enabled by the optically programmable assembly and manipulation of cells (e.g., bacterial, yeast and human) providing quantitative, multiparameter cell surface analysis by direct imaging as well as fractionation and sorting of mixed cell populationsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2004MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Oct 13, 2004ABN3ABANDONMENT - AFTER EX PARTE APPEAL
Oct 13, 2004EXPTEXPARTE APPEAL TERMINATED
Oct 13, 2004EXPTEXPARTE APPEAL TERMINATED
Jul 13, 2004EXPAEX PARTE APPEAL-REFUSAL AFFIRMED
Mar 12, 2004CNESEXAMINERS STATEMENT MAILED
Jan 21, 2004CFITCASE FILE IN TICRS
Jan 14, 2004JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 23, 2003CNCFCONTINUATION OF FINAL REFUSAL MAILED
Apr 22, 2003JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 22, 2003EXPIEX PARTE APPEAL-INSTITUTED
Apr 17, 2003EXAFEXPARTE APPEAL RECEIVED AT TTAB
Oct 2, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 29, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2002MAILPAPER RECEIVED
Feb 28, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2002DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance